Deb, W., Rosenfelt, C., Vignard, V., Papendorf, J.J., Möller, S., Wendlandt, M., Studencka-Turski, M., Cogné, B., Besnard, T., Ruffier, L., Toutain, B., Poirier, L., Cuinat, S., Kritzer, A., Crunk, A., diMonda, J., Vengoechea, J., Mercier, S., Kleinendorst, L., van Haelst, M.M., Zuurbier, L., Sulem, T., Katrínardóttir, H., Friðriksdóttir, R., Sulem, P., Stefansson, K., Jonsdottir, B., Zeidler, S., Sinnema, M., Stegmann, A.P.A., Naveh, N., Skraban, C.M., Gray, C., Murrell, J.R., Isikay, S., Pehlivan, D., Calame, D.G., Posey, J.E., Nizon, M., McWalter, K., Lupski, J.R., Isidor, B., Bolduc, F.V., Bézieau, S., Krüger, E., Küry, S., Ebstein, F. (2024). PSMD11 loss-of-function variants correlate with a neurobehavioral phenotype, obesity, and increased interferon response.
Am. J. Hum. Genet. 111(7): 1352--1369.